# Secretin Activates Human Brown Fat and Induces Satiation.

> **NCT03290846** · PHASE2,PHASE3 · COMPLETED · sponsor: **Turku University Hospital** · enrollment: 23 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Secretin Human
- **DRUG:** Saline Solution
- **OTHER:** Cold exposure

## Key facts

- **NCT ID:** NCT03290846
- **Lead sponsor:** Turku University Hospital
- **Sponsor class:** OTHER_GOV
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-08-02
- **Primary completion:** 2019-10-30
- **Final completion:** 2019-11-30
- **Target enrollment:** 23 (ACTUAL)
- **Last updated:** 2019-12-23

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03290846

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03290846, "Secretin Activates Human Brown Fat and Induces Satiation.". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03290846. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*